Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00575042Phase 2Completed
Phase 2, open-label trial of fenofibrate in primary biliary cholangitis (PBC), sponsored by University of Florida. Primary endpoints: Alkaline Phosphatase at 1 year and Immunoglobulin M at 1 year. Started Aug 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00575042.